logo
How Trump's Medicaid Crackdown Is Fueling This $22-Million Backed Healthcare Startup's Expansion

How Trump's Medicaid Crackdown Is Fueling This $22-Million Backed Healthcare Startup's Expansion

Forbes4 days ago
Nikita Singareddy (middle) and her cofounders Courtesy of Andreessen Horowitz
When Nikita Singareddy, Cydney Kim, and Ben Wesner first thought up Fortuna Health from a Crown Heights apartment, they saw opportunity in one of the least modern but most utilized corners of American healthcare: Medicaid. The legacy program offers free health insurance to 80 million Americans, but the current enrollment process is complex, slow and sometimes entirely paper-based. To bring a much-needed software update to the nearly $870 billion government program, the three founders leveraged their backgrounds in healthcare, strategic operations and technology to launch Fortuna in 2023.
The SaaS startup offers a user-friendly web-app for patients to easily submit and renew their Medicaid applications. While the typical enrollment process requires users to send materials online or via snail mail—then wait upwards of 45 days for a decision—Fortuna completes it in under a minute thanks to its AI models that flag common errors like missing pay stubs on employment verification forms. Fortuna makes money by selling its technology to insurance agencies and hospitals, which benefit from keeping patients insured because it increases the amount of money they get from the state.
Here's how it works. After a person applies to Medicaid, their provider sends a push notification powered by Fortuna, directing them to an online portal with instructions for accessing benefits. Fortuna's software then guides them through a personalized and multilingual experience—similar to a one-on-one interaction—that can respond to unique situations such as households with a mixed immigration status or seasonal employees who don't earn income throughout the year.
Last week Fortuna Health closed an $18 million Series A led by returning investor Andreessen Horowitz. The goal? Expand its service into more U.S. states and territories (they're currently active in eight) and the development of AI-powered workflows. The Series A brings their total funding to $22 million. Nikita Singareddy declined to comment on Fortuna Health's most recent valuation.
'We've experienced an 11x increase in users since last year and the growth is not entirely new,' Singareddy said. 'But because we've already laid the groundwork with our partners we have seen more customers that are ready to activate with this new sense of urgency.'
Singareddy, a healthcare policy wonk who got her start interning on Capitol Hill in college, worked on different sides of the healthcare industry from insurer Oscar to venture firm RRE Ventures. But it wasn't until her work at a Federally Qualified Community Health Center, otherwise known as 'free clinics,' where she saw firsthand how outdated technology created a barrier for people to access Medicaid. Experts estimate that 70% of Medicaid churn—which is when eligible people lose coverage—is due to procedural hiccups that could have been avoided with clearer instructions.
'There is a totally different healthcare system for people who are lower income and under-resourced versus commercial health insurance,' Singareddy told Forbes . 'Coming from policy being my area of passion, I saw that discrepancy and wanted to solve it.'
Fortuna raised its seed round shortly after the Medicaid unwinding period when pandemic-era protections expired and members had to verify that they still qualified for the program. Health plans and states needed a tech-enabled third party to manage the millions who suddenly lost coverage, generating early traction for Fortuna in the Medicaid SaaS field that has few competitors.
'We always say there are no bad ideas, just bad timing and what generated so much momentum for Fortuna is that they picked the perfect time to enter the market,' says Julie Yoo, a healthcare investor at Andreessen Horowitz.
Two years later, the startup is generating more momentum—thanks to politics. President Trump signed the One Big Beautiful Bill Act into law on July 4, which includes strict oversight on Medicaid, making the already analog process more complex like increasing the frequency in which users have to renew their coverage from once a year to every six months, and a new 80-hour work month requirement with additional documents required to prove employment.
'We've never wavered from our mission to be the TurboTax for Medicaid but the bill has forced our hand to move quicker on expanding into all 56 U.S. states and territories that have Medicaid programs,' Singareddy said.
While fully integrated into eight states, Fortuna has yet to scale nationally. The latest Series A will go toward building infrastructure to meet demands in new territories, but entering new markets will require a go-to-market strategy tailored to each state's unique Medicaid system. To apply for Medicaid via Fortuna, enrollees need their health provider to grant them access to the platform. That makes securing contracts with insurers, hospitals and health plans in each region critical for the startup's growth.
'They're only in a handful of states, so they either need a major payer or health system to get behind them in each new market,' a healthcare analyst at William Blair Ryan Daniels said. 'But how do you get them on board without consumer awareness? And how do you drive consumer awareness without the payer behind you? It's the classic chicken and egg problem.'
The One Big Beautiful Bill itself could mitigate this problem as Singareddy says Fortuna has already seen an increase of general inquiries from users about how the policy changes will affect their coverage. Fortuna is also building localized relationships with organizations at the state and county level to drive consumer awareness in new regions.
'We are not new to this problem. We didn't get created just to solve the Big Beautiful Bill,' Singareddy said. 'I'm glad we've spent so much time obsessing over how to modernize Medicaid so that we can be in the hands of many more people for this moment.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MetLife (MET) To Report Earnings Tomorrow: Here Is What To Expect
MetLife (MET) To Report Earnings Tomorrow: Here Is What To Expect

Yahoo

time3 minutes ago

  • Yahoo

MetLife (MET) To Report Earnings Tomorrow: Here Is What To Expect

Global insurance giant MetLife (NYSE:MET) will be reporting results this Wednesday afternoon. Here's what investors should know. MetLife beat analysts' revenue expectations by 3% last quarter, reporting revenues of $18.83 billion, up 10.6% year on year. It was a slower quarter for the company, with a significant miss of analysts' book value per share estimates and a miss of analysts' EPS estimates. Is MetLife a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting MetLife's revenue to be flat year on year at $18.64 billion, in line with its flat revenue from the same quarter last year. Adjusted earnings are expected to come in at $2.16 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. MetLife has missed Wall Street's revenue estimates four times over the last two years. Looking at MetLife's peers in the life insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Corebridge Financial delivered year-on-year revenue growth of 5.8%, beating analysts' expectations by 7.3%, and Lincoln Financial Group reported revenues up 4.4%, topping estimates by 1.1%. Lincoln Financial Group traded up 7.8% following the results. Read our full analysis of Corebridge Financial's results here and Lincoln Financial Group's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the life insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.9% on average over the last month. MetLife is down 5.3% during the same time and is heading into earnings with an average analyst price target of $94.14 (compared to the current share price of $75). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

HubSpot (HUBS) Reports Q2: Everything You Need To Know Ahead Of Earnings
HubSpot (HUBS) Reports Q2: Everything You Need To Know Ahead Of Earnings

Yahoo

time3 minutes ago

  • Yahoo

HubSpot (HUBS) Reports Q2: Everything You Need To Know Ahead Of Earnings

Sales and marketing software maker HubSpot (NYSE:HUBS) will be announcing earnings results this Wednesday afternoon. Here's what to look for. HubSpot beat analysts' revenue expectations by 2% last quarter, reporting revenues of $714.1 million, up 15.7% year on year. It was a strong quarter for the company, with an impressive beat of analysts' billings estimates and a solid beat of analysts' EBITDA estimates. It added 10,319 customers to reach a total of 258,258. Is HubSpot a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting HubSpot's revenue to grow 16% year on year to $739.3 million, slowing from the 20.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.12 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. HubSpot has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 3.1% on average. Looking at HubSpot's peers in the sales and marketing software segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Freshworks delivered year-on-year revenue growth of 17.5%, beating analysts' expectations by 2.9%, and BigCommerce reported revenues up 3.2%, topping estimates by 1.3%. Freshworks traded down 2.5% following the results while BigCommerce was up 4.6%. Read our full analysis of Freshworks's results here and BigCommerce's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the sales and marketing software stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3% on average over the last month. HubSpot is down 7.8% during the same time and is heading into earnings with an average analyst price target of $736.74 (compared to the current share price of $512.20). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Primerica Earnings: What To Look For From PRI
Primerica Earnings: What To Look For From PRI

Yahoo

time3 minutes ago

  • Yahoo

Primerica Earnings: What To Look For From PRI

Financial services company Primerica (NYSE:PRI) will be reporting results this Wednesday after market hours. Here's what to expect. Primerica beat analysts' revenue expectations by 2.1% last quarter, reporting revenues of $803.6 million, up 9.4% year on year. It was a mixed quarter for the company, with net premiums earned in line with analysts' estimates but a slight miss of analysts' book value per share estimates. Is Primerica a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Primerica's revenue to grow 6.1% year on year to $786.1 million, slowing from the 9.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $5.20 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Primerica has missed Wall Street's revenue estimates four times over the last two years. Looking at Primerica's peers in the life insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Corebridge Financial delivered year-on-year revenue growth of 5.8%, beating analysts' expectations by 7.3%, and Lincoln Financial Group reported revenues up 4.4%, topping estimates by 1.1%. Lincoln Financial Group traded up 7.8% following the results. Read our full analysis of Corebridge Financial's results here and Lincoln Financial Group's results here. The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the life insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.9% on average over the last month. Primerica is down 2.8% during the same time and is heading into earnings with an average analyst price target of $307.29 (compared to the current share price of $265.39). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store